Rosuvastatin Completed Phase 1 Trials for Squamous Cell Carcinoma (SCC) / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

Indications	Status	Purpose	Phase
DBCOND0043488 (Squamous Cell Carcinoma (SCC)) DBCOND0046916 (Lung Cancer Non-Small Cell Cancer (NSCLC))	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00966472	Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC	Erlotinib (DB00530) Rosuvastatin (DB01098)
NCT02317016	Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer	Rosuvastatin (DB01098) Osimertinib (DB09330)